SS&C Intralinks Success Stories
We’ve helped clients in nearly every country and industry throughout the world with secure innovative, productivity-driving solutions for high-value M&A, debt capital markets and banking transactions.
Here are just a few of our recent success stories. We’d love to add your brand to our hall of fame.
USD 1.1 billion
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its PARAGARD® intrauterine device business to CooperSurgical for USD 1.1 billion.
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its PARAGARD® intrauterine device business to CooperSurgical for USD 1.1 billion.
USD 68.5 billion
Express Scripts Holding Company, a listed US-based provider of integrated pharmacy benefit management services, used Intralinks for its acquisition by Cigna Corporation for USD 68.5 billion.
USD 77.0 billion
Aetna, a listed US-based provider of health insurance products and health care benefits services, used Intralinks for its acquisition by CVS Health Corporation for USD 77.0 billion.
USD 5.2 billion
ARIAD Pharmaceuticals
used Intralinks in its acquisition by Takeda Pharmaceutical Company for USD 5.2 billion.
used Intralinks in its acquisition by Takeda Pharmaceutical Company for USD 5.2 billion.
USD 1.5 billion
DuPage Medical Group,
a US multi-speciality physician group, used Intralinks to facilitate an investment of USD 1.5 billion by private equity funds managed by Ares Management.
a US multi-speciality physician group, used Intralinks to facilitate an investment of USD 1.5 billion by private equity funds managed by Ares Management.
USD 605 million
LDI Integrated Pharmacy Services, a US-based full- service pharmacy benefit manager, used Intralinks for its acquisition by Diplomat Pharmacy from Nautic Partners and Oak HC/FT for USD 605 million.
USD 1.1 billion
NeuroDerm,
an Israel-based pharmaceutical firm developing next-generation treatments for central nervous system disorders, used Intralinks for its acquisition by Mitsubishi Tanabe Pharma Corporation for USD 1.1 billion.
an Israel-based pharmaceutical firm developing next-generation treatments for central nervous system disorders, used Intralinks for its acquisition by Mitsubishi Tanabe Pharma Corporation for USD 1.1 billion.
USD 2.0 billion
Spectranetics Corporation,
a US-based manufacturer and distributor of cardiovascular medical devices, used Intralinks in its acquisition by Koninklijke Philips for USD 2.0 billion.
a US-based manufacturer and distributor of cardiovascular medical devices, used Intralinks in its acquisition by Koninklijke Philips for USD 2.0 billion.
USD 675 million
Teva Pharmaceutical Industries,
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its emergency contraception brands portfolio to Foundation Consumer Healthcare for USD 675 million.
the Israel-based world leader in generic pharmaceuticals, used Intralinks to divest its emergency contraception brands portfolio to Foundation Consumer Healthcare for USD 675 million.
€5.7 billion
STADA Arzneimittel,
a German, listed pharmaceutical and healthcare company, used Intralinks for its acquisition by Bain Capital and Cinven Partners for €5.7 billion.
a German, listed pharmaceutical and healthcare company, used Intralinks for its acquisition by Bain Capital and Cinven Partners for €5.7 billion.